Latest Executive Appointment News

Astral Resources reports robust exploration results across its Western Australian gold projects and key progress on the Mandilla Definitive Feasibility Study, alongside a new joint venture at the Think Big deposit.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Nuix Limited has appointed John Ruthven as interim CEO following Jonathan Rubinsztein's departure, initiating a 12-month leadership transition period.

Boom Logistics reports steady revenue growth and significant capital expenditure cuts in Q1 FY26, while advancing a share buyback and navigating leadership changes.

Coventry Group reports a 4.5% increase in Q1 FY26 sales alongside a notable EBITDA turnaround, underpinned by a $10 million cost-out program and fresh executive appointments.

VHM Limited has secured a significant offtake framework with Mitsui and a US$200 million financing interest from the US Export-Import Bank for its Goschen Rare Earths and Mineral Sands Project, alongside key environmental approvals. These milestones set the stage for a Final Investment Decision in the first half of 2026.

Australian Unity Limited has appointed Kelly Bayer Rosmarin as its next Group Managing Director and CEO, succeeding Rohan Mead after his 21-year tenure. Bayer Rosmarin’s leadership is expected to drive the company’s strategic transformation and growth in wellbeing services.

Vanadium Resources Limited is advancing multiple offtake discussions for its Steelpoortdrift project, with competing proposals offering improved terms over existing agreements. Operational readiness steps are progressing, including key executive appointments and contractor finalisations.

JAYRIDE Group Limited has confirmed Randy Prado as CEO and Ram Navaratnam as Finance Director, cementing leadership as it advances its SaaS mobility platform with pilots in Southeast Asia.

Spenda Limited announces the resignation of CEO Adrian Floate due to health concerns, appointing COO Corrie Hassan as interim CEO and welcoming Francis DeSouza to the Board. The company aims to maintain momentum following a record revenue year.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.